NASDAQ : ESLA

Estrella Immunopharma, Inc. — Earnings Estimates

$0.739 USD

$0.02 (2.28%)

Volume
16.41K
Average Volume
39.19K
Market Capitalization
$31.53M
P/E Ratio
-2.13
Dividend Yield
0.00%
Price Target
Year High
$3.15
Year Low
$0.68
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$0.24

Annual earnings financials

ESLA financial data with annual/quarterly toggle

ESLA GAAP EPS - Annual & Quarterly

ESLA Sales Revenue - Annual & Quarterly

ESLA Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

ESLA Estimated and Actual Revenue by Quarter
ESLA Estimated and Actual EPS by Quarter
ESLA Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-06-30 1 - - - - - -
2028-03-31 1 - - - - - -
2027-12-31 1 - - - - - -
2027-09-30 1 - - - - - -
2027-06-30 0 - - - - - -
2027-03-31 0 - - - - - -
ESLA Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-06-30 1 -930.88K -930.88K -930.88K - - -
2028-03-31 1 -1.46M -1.46M -1.46M - - -
2027-12-31 1 -1.78M -1.78M -1.78M - - -
2027-09-30 1 -2.21M -2.21M -2.21M - - -
2027-06-30 0 -4.61M -4.61M -4.61M - - -
2027-03-31 0 -4.89M -4.89M -4.89M - - -
ESLA Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-06-30 1 26.69M 26.69M 26.69M 1 -0.0221 -0.0221 -0.0221
2028-03-31 1 25.71M 25.71M 25.71M 1 -0.0347 -0.0347 -0.0347
2027-12-31 1 23.73M 23.73M 23.73M 1 -0.0422 -0.0422 -0.0422
2027-09-30 1 22.74M 22.74M 22.74M 1 -0.0525 -0.0525 -0.0525
2027-06-30 0 - - - 1 -0.1095 -0.1095 -0.1095
2027-03-31 0 - - - 1 -0.1161 -0.1161 -0.1161